Matrixyl (Palmitoyl): what it is and what the evidence says
A topical peptide studied for its relationship with collagen-synthesis signaling and skin firmness. It is the KTTKS fragment of type I procollagen joined to palmitic acid, which helps it enter the stratum corneum.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
In aesthetics the route of administration decides almost everything. A peptide that works in a fibroblast culture may not cross intact skin, and then the formulation matters more than the active ingredient. That is why two products listing the same ingredient can give completely different results.
What it is studied for
Firmness, collagen, skin texture.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
In people there is one randomized, double-blind, vehicle-controlled trial (2005, 93 women, 12 weeks, split-face) that showed fewer fine lines and wrinkles, and a 2023 placebo-controlled pilot in 21 women that favored the peptide on photographs and satisfaction without reaching statistical significance. A 2010 trial in 196 women tested it as part of a regimen with several active ingredients.
The limitation that matters most
Larger and longer independent trials with direct measurement of collagen in the skin are still missing, as are studies of the peptide alone, because many products pair it with other actives. The main trial was run by Procter & Gamble, and the penetration data collected in the CIR report come from mouse skin.
Regulatory status
A cosmetic ingredient, not a medicine, so it does not go through FDA or EMA approval. In November 2024 the U.S. Expert Panel for Cosmetic Ingredient Safety (CIR) concluded in its final report that it is safe in the present practices of use and concentration. It does not appear on the WADA Prohibited List.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
It is for topical use on intact skin, and its results are gradual and depend on the formulation. Watch how the skin tolerates the vehicle, with comedones or milia in oily skin and irritation around the eyes, and check that the INCI list states Palmitoyl Pentapeptide-4.
With reactive skin, rosacea, active dermatitis, or a recent dermatologic procedure, validate the product with a dermatologist before starting.
What this page cannot give you
A reference page can take you this far. You know what Matrixyl (Palmitoyl) is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a Certificate of Completion with a verifiable certificate ID, a Progress Tracker to follow how you are doing, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Topical palmitoyl pentapeptide provides improvement in photoaged human facial skinhuman Int J Cosmet Sci · 2005 · PMID 18492182 →
- Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feethuman J Clin Aesthet Dermatol · 2023 · PMID 36909866 →
- Matrikines in the skin: Origin, effects, and therapeutic potentialreview Pharmacol Ther · 2024 · PMID 38917886 →
- The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic Activitypreclinical Molecules · 2019 · PMID 31618846 →
- Boosting Cosmeceutical Peptides: Coupling Imidazolium-Based Ionic Liquids to Pentapeptide-4 Originates New Leads with Antimicrobial and Collagenesis-Inducing Activitiespreclinical Microbiol Spectr · 2022 · PMID 35950860 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Matrixyl (Palmitoyl) or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Matrixyl (Palmitoyl)?
A topical peptide studied for its relationship with collagen-synthesis signaling and skin firmness. It is the KTTKS fragment of type I procollagen joined to palmitic acid, which helps it enter the stratum corneum. It is studied within the area of aesthetic.
Is there human evidence for Matrixyl (Palmitoyl)?
In people there is one randomized, double-blind, vehicle-controlled trial (2005, 93 women, 12 weeks, split-face) that showed fewer fine lines and wrinkles, and a 2023 placebo-controlled pilot in 21 women that favored the peptide on photographs and satisfaction without reaching statistical significance. A 2010 trial in 196 women tested it as part of a regimen with several active ingredients.
Is it approved by any health agency?
A cosmetic ingredient, not a medicine, so it does not go through FDA or EMA approval. In November 2024 the U.S. Expert Panel for Cosmetic Ingredient Safety (CIR) concluded in its final report that it is safe in the present practices of use and concentration. It does not appear on the WADA Prohibited List.
What is the dose of Matrixyl (Palmitoyl)?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Matrixyl (Palmitoyl) is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.